Cargando…
Designing and building oncolytic viruses
Oncolytic viruses (OVs) are engineered and/or evolved to propagate selectively in cancerous tissues. They have a dual mechanism of action; direct killing of infected cancer cells cross-primes anticancer immunity to boost the killing of uninfected cancer cells. The goal of the field is to develop OVs...
Autores principales: | Maroun, Justin, Muñoz-Alía, Miguel, Ammayappan, Arun, Schulze, Autumn, Peng, Kah-Whye, Russell, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779534/ https://www.ncbi.nlm.nih.gov/pubmed/29387140 http://dx.doi.org/10.2217/fvl-2016-0129 |
Ejemplares similares
-
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
por: Russell, Luke, et al.
Publicado: (2019) -
Collateral Lethal Effects of Complementary Oncolytic Viruses
por: Maroun, Justin W., et al.
Publicado: (2020) -
ONCOLYTIC VIROTHERAPY
por: Russell, Stephen J, et al.
Publicado: (2012) -
A brief review of reporter gene imaging in oncolytic virotherapy and gene therapy
por: Concilio, Susanna C., et al.
Publicado: (2021) -
Oncolytic Viruses for Malignant Glioma: On the Verge of Success?
por: Suryawanshi, Yogesh R., et al.
Publicado: (2021)